Hui-KuoGeorgeShuMD

Radiation Oncology • Atlanta, GA

Professor, Radiation Oncology, Emory University School of Medicine

Join to view full profile

Dr. Shu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shu's full profile

Already have an account?

Office
1365 Clifton Rd Ne
CT-104
Atlanta, GA 30322
Phone+1 404-778-3473

Fax+1 404-778-3670

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1994 - 1999
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1994
Case Western Reserve University School of MedicineClass of 1993

Certifications & Licensure

CA State Medical License 1995 - Present
GA State Medical License 2005 - 2025
NJ State Medical License 2002 - 2007
PA State Medical License 1999 - 2006
American Board of Radiology Radiation Oncology

Clinical Trials

Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc Start of enrollment: 2010 Sep 22
Completed
Not Applicable
MRSI to Predict Response to RT/TMZ ± Belinostat in GBM Start of enrollment: 2014 May 07
Active, not recruiting
Phase 2
Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma Start of enrollment: 2017 Sep 20
Active, not recruiting
Phase 2
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases Start of enrollment: 2018 Nov 28
Completed
Not Applicable
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Active, not recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy.
Yevgeniy Vinogradskiy, Houda Bahig, Nicholas W Bucknell, Jeffrey Buchsbaum, Hui-Kuo George Shu
Tomography. 2024-11-14
Deep learning based apparent diffusion coefficient map generation from multi-parametric MR images for patients with diffuse gliomas.
Zach Eidex, Mojtaba Safari, Jacob Wynne, Richard L J Qiu, Tonghe Wang
Medical Physics. 2024-11-08
Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.
Neal S McCall, Annabel Lu, Benjamin D Hopkins, David Qian, Kimberly B Hoang
Journal of Neurosurgery. 2024-11-01

Journal Articles

Fractionated Radiotherapy Is Associated with Lower Rates of Treatment-Related Edema Than Stereotactic Radiosurgery in MRI-Defined Meningiomas
Bree R Eaton, Ian R Crocker, Arif N Ali, Hui-Kuo G Shu, World Neurosurgery

Authored Content

Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018

Press Mentions

Advanced 3D MRI Technology Marks a Leap Forward in Glioblastoma ImagingMay 9th, 2016

Professional Memberships

American Society of Clinical Oncology - ASCO
Member